Concepts (148)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Connexin 43 | 14 | 2021 | 62 | 3.360 |
Why?
|
| Gap Junctions | 6 | 2014 | 29 | 1.110 |
Why?
|
| Tissue Engineering | 3 | 2018 | 212 | 1.000 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2017 | 234 | 0.960 |
Why?
|
| NAV1.5 Voltage-Gated Sodium Channel | 2 | 2013 | 6 | 0.860 |
Why?
|
| ras Proteins | 2 | 2020 | 102 | 0.830 |
Why?
|
| Peptides | 4 | 2021 | 455 | 0.800 |
Why?
|
| Myocytes, Cardiac | 3 | 2013 | 442 | 0.740 |
Why?
|
| Foreign-Body Reaction | 2 | 2015 | 24 | 0.710 |
Why?
|
| Connexins | 2 | 2018 | 35 | 0.690 |
Why?
|
| Adenosine Triphosphate | 2 | 2015 | 314 | 0.640 |
Why?
|
| Microtubules | 2 | 2017 | 104 | 0.630 |
Why?
|
| Signal Transduction | 4 | 2022 | 2689 | 0.580 |
Why?
|
| Cicatrix | 3 | 2021 | 60 | 0.570 |
Why?
|
| Bioartificial Organs | 1 | 2015 | 3 | 0.530 |
Why?
|
| Pancreas, Artificial | 1 | 2015 | 4 | 0.530 |
Why?
|
| Islets of Langerhans | 1 | 2015 | 87 | 0.500 |
Why?
|
| Peptide Fragments | 2 | 2015 | 483 | 0.490 |
Why?
|
| Inflammation | 4 | 2018 | 1030 | 0.480 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2015 | 101 | 0.480 |
Why?
|
| Receptors, Purinergic | 1 | 2014 | 10 | 0.470 |
Why?
|
| Pancreatitis, Chronic | 1 | 2015 | 168 | 0.460 |
Why?
|
| Breast Neoplasms | 3 | 2018 | 1536 | 0.440 |
Why?
|
| Antineoplastic Agents | 2 | 2020 | 1070 | 0.440 |
Why?
|
| Membrane Microdomains | 1 | 2013 | 32 | 0.430 |
Why?
|
| Prostheses and Implants | 1 | 2014 | 159 | 0.430 |
Why?
|
| Arrhythmias, Cardiac | 3 | 2013 | 239 | 0.420 |
Why?
|
| Heart Conduction System | 1 | 2013 | 119 | 0.410 |
Why?
|
| Neoplasms | 3 | 2020 | 1667 | 0.400 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2015 | 529 | 0.380 |
Why?
|
| Wound Healing | 4 | 2014 | 260 | 0.370 |
Why?
|
| Phosphoproteins | 2 | 2011 | 202 | 0.360 |
Why?
|
| Skin | 2 | 2009 | 451 | 0.310 |
Why?
|
| Animals | 15 | 2022 | 20881 | 0.290 |
Why?
|
| Mutation | 3 | 2022 | 1213 | 0.290 |
Why?
|
| Membrane Proteins | 2 | 2011 | 617 | 0.290 |
Why?
|
| Molecular Targeted Therapy | 2 | 2020 | 170 | 0.270 |
Why?
|
| HeLa Cells | 3 | 2017 | 237 | 0.260 |
Why?
|
| Humans | 24 | 2022 | 68618 | 0.230 |
Why?
|
| Cells, Cultured | 4 | 2019 | 2673 | 0.230 |
Why?
|
| Fibroblasts | 2 | 2021 | 902 | 0.230 |
Why?
|
| Protein Transport | 2 | 2017 | 280 | 0.230 |
Why?
|
| Nucleotides | 1 | 2022 | 29 | 0.200 |
Why?
|
| Genes, ras | 1 | 2022 | 46 | 0.200 |
Why?
|
| Dermis | 1 | 2021 | 29 | 0.190 |
Why?
|
| Action Potentials | 2 | 2013 | 223 | 0.190 |
Why?
|
| Myocardium | 3 | 2011 | 1204 | 0.180 |
Why?
|
| Autophagy-Related Proteins | 1 | 2019 | 17 | 0.170 |
Why?
|
| Oncogenes | 1 | 2020 | 71 | 0.170 |
Why?
|
| Phosphorylation | 2 | 2019 | 1200 | 0.160 |
Why?
|
| Pancreatic Neoplasms | 1 | 2022 | 332 | 0.160 |
Why?
|
| Microdissection | 1 | 2018 | 15 | 0.160 |
Why?
|
| Endothelial Cells | 2 | 2015 | 384 | 0.150 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2021 | 2083 | 0.150 |
Why?
|
| Autophagy | 1 | 2019 | 208 | 0.150 |
Why?
|
| Cell Differentiation | 1 | 2021 | 1034 | 0.140 |
Why?
|
| Molecular Mimicry | 1 | 2015 | 13 | 0.130 |
Why?
|
| Coculture Techniques | 1 | 2015 | 147 | 0.130 |
Why?
|
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2015 | 4 | 0.130 |
Why?
|
| Immunity, Innate | 1 | 2015 | 156 | 0.120 |
Why?
|
| Tamoxifen | 1 | 2015 | 62 | 0.120 |
Why?
|
| Quinazolines | 1 | 2015 | 70 | 0.120 |
Why?
|
| Rats | 3 | 2021 | 5300 | 0.120 |
Why?
|
| Disease Progression | 1 | 2018 | 1038 | 0.120 |
Why?
|
| Extracellular Space | 1 | 2014 | 121 | 0.110 |
Why?
|
| Zonula Occludens-1 Protein | 2 | 2011 | 25 | 0.110 |
Why?
|
| Kidney | 1 | 2018 | 945 | 0.110 |
Why?
|
| Drug Delivery Systems | 1 | 2015 | 236 | 0.110 |
Why?
|
| Insulin | 1 | 2015 | 619 | 0.100 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2013 | 98 | 0.100 |
Why?
|
| Extracellular Matrix | 2 | 2021 | 493 | 0.100 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2011 | 28 | 0.100 |
Why?
|
| Protein Binding | 2 | 2011 | 1027 | 0.100 |
Why?
|
| Biomimetic Materials | 1 | 2011 | 20 | 0.100 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2011 | 57 | 0.090 |
Why?
|
| Immunoprecipitation | 1 | 2011 | 132 | 0.090 |
Why?
|
| Green Fluorescent Proteins | 1 | 2011 | 200 | 0.090 |
Why?
|
| Cell Communication | 1 | 2011 | 116 | 0.090 |
Why?
|
| Up-Regulation | 1 | 2013 | 682 | 0.090 |
Why?
|
| Kidney Transplantation | 1 | 2018 | 839 | 0.090 |
Why?
|
| Blotting, Western | 1 | 2012 | 954 | 0.090 |
Why?
|
| RNA Interference | 1 | 2011 | 266 | 0.090 |
Why?
|
| Myocardial Ischemia | 1 | 2011 | 172 | 0.090 |
Why?
|
| Cell Cycle | 1 | 2011 | 312 | 0.090 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 1174 | 0.090 |
Why?
|
| Cell Membrane | 1 | 2011 | 525 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 2791 | 0.080 |
Why?
|
| RNA, Small Interfering | 1 | 2011 | 434 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 2 | 2015 | 322 | 0.080 |
Why?
|
| Protein Engineering | 1 | 2008 | 35 | 0.080 |
Why?
|
| Amino Acid Sequence | 2 | 2015 | 1083 | 0.070 |
Why?
|
| Embryo, Mammalian | 1 | 2008 | 176 | 0.070 |
Why?
|
| Fetus | 1 | 2008 | 157 | 0.070 |
Why?
|
| Time Factors | 1 | 2015 | 4655 | 0.070 |
Why?
|
| Molecular Sequence Data | 2 | 2015 | 1447 | 0.070 |
Why?
|
| Female | 7 | 2021 | 38074 | 0.070 |
Why?
|
| Cardiovascular Diseases | 1 | 2014 | 940 | 0.070 |
Why?
|
| Flufenamic Acid | 1 | 2015 | 3 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 1 | 2008 | 384 | 0.060 |
Why?
|
| Biotinylation | 1 | 2015 | 27 | 0.060 |
Why?
|
| Silicones | 1 | 2015 | 32 | 0.060 |
Why?
|
| Collagen | 1 | 2008 | 636 | 0.060 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2015 | 137 | 0.060 |
Why?
|
| Antibodies, Heterophile | 1 | 2004 | 11 | 0.060 |
Why?
|
| Neutrophils | 1 | 2015 | 204 | 0.060 |
Why?
|
| Cell Line, Tumor | 2 | 2022 | 1851 | 0.060 |
Why?
|
| Lipoproteins, LDL | 1 | 2004 | 343 | 0.050 |
Why?
|
| Autoantibodies | 1 | 2004 | 434 | 0.050 |
Why?
|
| Mice | 3 | 2022 | 8474 | 0.050 |
Why?
|
| Guinea Pigs | 1 | 2021 | 124 | 0.050 |
Why?
|
| Macrophages | 1 | 2015 | 647 | 0.050 |
Why?
|
| Calcium | 1 | 2015 | 929 | 0.050 |
Why?
|
| Phagosomes | 1 | 2019 | 19 | 0.040 |
Why?
|
| Allosteric Regulation | 1 | 2019 | 58 | 0.040 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2019 | 100 | 0.040 |
Why?
|
| Alternative Splicing | 1 | 2019 | 93 | 0.040 |
Why?
|
| Small Molecule Libraries | 1 | 2019 | 53 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2019 | 326 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2019 | 284 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2022 | 1174 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2019 | 511 | 0.040 |
Why?
|
| Male | 4 | 2021 | 37321 | 0.030 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2016 | 114 | 0.030 |
Why?
|
| Central Nervous System Diseases | 1 | 2014 | 40 | 0.030 |
Why?
|
| Adult | 2 | 2011 | 21403 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2015 | 214 | 0.030 |
Why?
|
| Skin Diseases | 1 | 2014 | 122 | 0.030 |
Why?
|
| Tight Junctions | 1 | 2011 | 25 | 0.020 |
Why?
|
| Protein Interaction Mapping | 1 | 2011 | 62 | 0.020 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2011 | 141 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2011 | 546 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 2011 | 738 | 0.020 |
Why?
|
| Models, Biological | 1 | 2009 | 981 | 0.020 |
Why?
|
| Cross Reactions | 1 | 2004 | 57 | 0.020 |
Why?
|
| Apolipoproteins B | 1 | 2004 | 29 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 2004 | 98 | 0.010 |
Why?
|
| Epitopes | 1 | 2004 | 146 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2009 | 807 | 0.010 |
Why?
|
| Rabbits | 1 | 2004 | 509 | 0.010 |
Why?
|
| Glycation End Products, Advanced | 1 | 2004 | 125 | 0.010 |
Why?
|
| Antigen-Antibody Complex | 1 | 2004 | 175 | 0.010 |
Why?
|
| Sulfobromophthalein | 1 | 1973 | 2 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 1973 | 119 | 0.010 |
Why?
|
| Liver Function Tests | 1 | 1973 | 114 | 0.010 |
Why?
|
| Heart | 1 | 2006 | 850 | 0.010 |
Why?
|
| Rose Bengal | 1 | 1973 | 3 | 0.000 |
Why?
|
| Methods | 1 | 1973 | 156 | 0.000 |
Why?
|
| Liver Diseases | 1 | 1973 | 193 | 0.000 |
Why?
|